Greg Pyszczymuka
Corporate Officer/Principal at AYTU BIOPHARMA, INC.
Net worth: 64 661 $ as of 2024-04-29
Profile
Greg Pyszczymuka is currently working as the Vice President-Commercial at Neos Therapeutics, Inc. since 2020.
He is also currently serving as the Chief Commercial Officer at Aytu Biopharma, Inc. In terms of education, Mr. Pyszczymuka holds an MBA from Argosy University and an undergraduate degree from Rutgers State University of New Jersey.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
AYTU BIOPHARMA, INC.
0.41% | 2024-03-30 | 22,768 ( 0.41% ) | 64 661 $ | 2024-04-29 |
Greg Pyszczymuka active positions
| Companies | Position | Start |
|---|---|---|
| AYTU BIOPHARMA, INC. | Corporate Officer/Principal | - |
| NEOS THERAPEUTICS, INC. | Corporate Officer/Principal | 2018-10-31 |
Training of Greg Pyszczymuka
| Argosy University | Masters Business Admin |
| Rutgers State University of New Jersey | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AYTU BIOPHARMA, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Neos Therapeutics, Inc.
 Neos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Neos Therapeutics, Inc is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Its products are Adzenys XR-ODT (amphetamine), Cotempla XR-ODT (methylphenidate), and Adzenys-ER (amphetamine) extended-release oral suspension, all for the treatment of ADHD, are the first three approved products using the Company's extended-release technology platform. The firm manufactures and markets its generic version of the branded product Tussionex, an extended-release oral suspension of hydrocodone and chlorpheniramine for the relief of cough and upper respiratory symptoms of a cold. The company was founded by Darlene R. Ryan on November 30, 1994 and is headquartered in Grand Prairie, TX. | Health Technology |
- Stock Market
- Insiders
- Greg Pyszczymuka
